| Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc |
| Journal website https://www.journalmc.org |
Case Report
Volume 12, Number 5, May 2021, pages 190-194
The Role of a Medical Intermediate Care Unit in the Management of Budd-Chiari Syndrome: Case Series
Table
| Case Nr | Age of diagnose | Etiology | Clinical presentation | Progression to ALF | Peak ALT (U/L) | Peak INR | Peak serum creatinine (mg/dL) | Admission Child-Pugh score | Admission MELD-Na score | Admission Rotterdam score | Admission BCS TIPS PI score | Therapeutic strategy | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nr: number; ALT: alanine aminotransferase; APS: antiphospholipid syndrome; ALI: acute liver injury; ALF: acute liver failure; AST: aspartate aminotransferase; INR: international normalized ratio; MELD-Na: model of end-stage liver disease-sodium; BCS TIPS PI score: Budd-Chiari syndrome- transjugular intra-hepatic portosystemic shunting prognostic index score. | |||||||||||||
| 1 | 18 | APS | Subacute on chronic | No | 11 | 1.1 | 0.6 | 5 | 9 | Class I 0.724 | 4.62 | Anticoagulation, antiaggregation, plasmapheresis, rituximab | Survived |
| 2 | 29 | APS | ALI | No | 186 | 4.45 | 0.71 | 10 | 26 | Class III 2.03 | 4.67 | Anticoagulation, stent | Survived |
| 3 | 29 | Acute myeloid leukemia | ALI | Yes | 3797 | 4.1 | 1.8 | 11 | 28 | Class III 1.92 | 5.33 | None | Death |
| 4 | 51 | Primary Myelofibrosis | ALI | Yes | 131 | 1.95 | 4.6 | 11 | 33 | Class III 1.82 | 7.16 | Anticoagulation, antiaggregation, cytoreductive therapy | Death |
| 5 | 47 | Inconclusive | ALF | Yes | 194 | 2.6 | 0.97 | 11 | 28 | Class III 3.51 | 6.53 | Anticoagulation, antiaggregation, liver transplantation | Survived |